AU6331099A - Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders - Google Patents
Thiazolidine derivatives for the treatment and prevention of metabolic bone disordersInfo
- Publication number
- AU6331099A AU6331099A AU63310/99A AU6331099A AU6331099A AU 6331099 A AU6331099 A AU 6331099A AU 63310/99 A AU63310/99 A AU 63310/99A AU 6331099 A AU6331099 A AU 6331099A AU 6331099 A AU6331099 A AU 6331099A
- Authority
- AU
- Australia
- Prior art keywords
- prevention
- treatment
- bone disorders
- metabolic bone
- thiazolidine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98118539 | 1998-09-30 | ||
| EP98118539 | 1998-09-30 | ||
| PCT/EP1999/007252 WO2000018746A1 (en) | 1998-09-30 | 1999-09-30 | Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6331099A true AU6331099A (en) | 2000-04-17 |
Family
ID=8232727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU63310/99A Abandoned AU6331099A (en) | 1998-09-30 | 1999-09-30 | Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU6331099A (en) |
| WO (1) | WO2000018746A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0021421D0 (en) | 2000-08-31 | 2000-10-18 | Oxford Glycosciences Uk Ltd | Compounds |
| JP2003040877A (en) * | 2001-07-24 | 2003-02-13 | Sumika Fine Chemicals Co Ltd | Method for producing 5-[6-(2-fluorobenzyloxy)-2- naphthyl]methyl-2,4-thiazolidinedione and method for refining the same |
| WO2004043955A1 (en) * | 2002-11-13 | 2004-05-27 | Rigel Pharmaceuticals, Inc. | Rhodanine derivatives and pharmaceutical compositions containing them |
| WO2006019741A1 (en) * | 2004-07-14 | 2006-02-23 | Janssen Pharmaceutica N.V. | Arylidenes for the treatment of estrogen related receptor-alpha mediated diseases |
| CN1978445B (en) * | 2005-12-02 | 2010-09-01 | 中国科学院上海药物研究所 | Compound serving as human-derived adenoside mononucleoside activated protein kinase activator, and its preparing method and use |
| US8637558B2 (en) * | 2008-12-30 | 2014-01-28 | Industry-Academic Cooperation Foundation, Chosun University | Thiazolidinedione derivative and use thereof |
| CA2968884A1 (en) * | 2014-12-10 | 2016-06-16 | Massachusetts Institute Of Technology | Fused 1,3-azole derivatives useful for the treatment of proliferative diseases |
| CA3012846A1 (en) | 2016-02-16 | 2017-08-24 | Massachusetts Institute Of Technology | Max binders as myc modulators and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK4487A (en) * | 1986-01-07 | 1987-07-08 | Yamanouchi Pharma Co Ltd | HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE |
| GB8713861D0 (en) * | 1987-06-13 | 1987-07-15 | Beecham Group Plc | Compounds |
| US4897406A (en) * | 1987-11-13 | 1990-01-30 | Nisshin Flour Milling Co., Ltd. | Rhodanine derivatives and pharmaceutical compositions |
| DE69024843T2 (en) * | 1989-05-19 | 1996-05-30 | Nisshin Flour Milling Co | Rhodanine derivatives and pharmaceutical compositions |
| IL108962A (en) * | 1989-12-21 | 1996-12-05 | Lilly Co Eli | Use of hydroxybenzyl substituted sulfur containing heterocyclic derivatives a process for their preparation and pharmaceutical compositions containing them |
| US5143929A (en) * | 1991-05-09 | 1992-09-01 | Warner-Lambert Company | 2-substituted thiazolidinone, oxazolidinone, and imidazolidinone derivatives of fenamates as antiinflammatory agents |
| FR2680512B1 (en) * | 1991-08-20 | 1995-01-20 | Adir | NOVEL 2,4-THIAZOLIDINEDIONE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| FR2688220A1 (en) * | 1992-03-06 | 1993-09-10 | Adir | NOVEL THIAZOLIDINE-2,4-DIONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| US5476865A (en) * | 1994-07-06 | 1995-12-19 | Eli Lilly And Company | Methods of inhibiting bone loss |
| IL117208A0 (en) * | 1995-02-23 | 1996-06-18 | Nissan Chemical Ind Ltd | Indole type thiazolidines |
| EP0783888A1 (en) * | 1995-12-26 | 1997-07-16 | Sankyo Company Limited | Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis |
| GB9614402D0 (en) * | 1996-07-09 | 1996-09-04 | Smithkline Beecham Spa | Novel compounds |
| JPH10101659A (en) * | 1996-10-02 | 1998-04-21 | Nitto Chem Ind Co Ltd | Production of substituted thiazolidine-dione derivative |
-
1999
- 1999-09-30 AU AU63310/99A patent/AU6331099A/en not_active Abandoned
- 1999-09-30 WO PCT/EP1999/007252 patent/WO2000018746A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000018746A1 (en) | 2000-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
| AU4060599A (en) | Pharmaceutical composition for treating or preventing sleep disorders | |
| EP1143956A3 (en) | Compositions and methods for the treatment of anorectal disorders | |
| AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
| AU4241596A (en) | Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders | |
| AU2212299A (en) | Compositions and methods for the treatment of tumor | |
| AU6462500A (en) | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement | |
| AU2001247331A1 (en) | Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders | |
| IL143921A0 (en) | Compositions for the treatment and prevention of tumors and tumor-related disorders | |
| AU5309400A (en) | Methods and compositions for the treatment of neuroleptic and related disorders using sertindole derivatives | |
| AU7748000A (en) | Method and composition for the treatment of dermatologic diseases | |
| EP1191941A4 (en) | A method for the prophylaxis and/or treatment of medical disorders | |
| AU6910600A (en) | Methods for the treatment of mental disorders | |
| AU2463099A (en) | Gabapentin and its derivatives for the treatment of muscular and skeletal pain | |
| AU1774097A (en) | Pharmaceutical compositions for the treatment of rhinitis | |
| AU6330999A (en) | Rhodanine derivatives for the treatment and prevention of metabolic bone disorders | |
| AU6330799A (en) | Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders | |
| AU1509999A (en) | Herbal drug composition for the prevention and treatment of dementia | |
| AU2058697A (en) | Treatment of sleep disorders | |
| AU5908300A (en) | Prevention and treatment of amyloid-associated disorders | |
| AU4694999A (en) | Use of thiazolidinedione derivatives for the treatment or prevention of cataracts | |
| EP1126850A4 (en) | Treatment of disorders of the outer retina | |
| AU1742200A (en) | Prevention and treatment of amyloid-associated disorders | |
| AU6331099A (en) | Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders | |
| AU7601400A (en) | Treatment and prevention of hepatic disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |